{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:14:02Z","timestamp":1791522842201,"version":"4.3.4"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,7,10]]},"DOI":"10.1001\/jama.2018.8496","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T03:47:36Z","timestamp":1531280856000},"page":"156","source":"Crossref","is-referenced-by-count":397,"title":["Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits"],"prefix":"10.1001","volume":"320","author":[{"given":"Pooja","family":"Khatri","sequence":"first","affiliation":[{"name":"University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn O.","family":"Kleindorfer","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Devlin","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine, Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Robert N.","family":"Sawyer","sequence":"additional","affiliation":[{"name":"University of Buffalo, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Starr","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mejilla","sequence":"additional","affiliation":[{"name":"Dayton Medical Center, Department of Veterans Affairs, Dayton, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Broderick","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Jauch","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Levine","sequence":"additional","affiliation":[{"name":"SUNY Downstate Medical Center, Brooklyn, New York"},{"name":"Kings County Hospital Center, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Romano","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Saver","sequence":"additional","affiliation":[{"name":"Comprehensive Stroke Center and Department of Neurology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achala","family":"Vagal","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Purdon","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Devenport","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Pavlov","sequence":"additional","affiliation":[{"name":"Everest Clinical Research, Markham, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon D.","family":"Yeatts","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PRISMS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"15","key":"joi180069r1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1212\/WNL.0000000000003198","article-title":"Why are acute ischemic stroke patients not receiving IV tPA? results from a national registry.","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"joi180069r2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/STROKEAHA.109.572883","article-title":"What is a minor stroke?","volume":"41","author":"Fischer","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"joi180069r3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/STROKEAHA.110.593897","article-title":"Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke.","volume":"43","author":"Khatri","year":"2012","journal-title":"Stroke"},{"issue":"5","key":"joi180069r4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/CIRCOUTCOMES.111.000095","article-title":"Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines\u2013Stroke hospitals.","volume":"6","author":"Schwamm","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"joi180069r5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/STROKEAHA.117.019341","article-title":"Predictors of thrombolysis administration in mild stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.","volume":"49","author":"Asdaghi","year":"2018","journal-title":"Stroke"},{"issue":"9958","key":"joi180069r6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"joi180069r7","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"9834","key":"joi180069r8","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial.","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet"},{"key":"joi180069r9","article-title":"Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): rationale and design [published online January 1, 2018].","author":"Yeatts","journal-title":"Int J Stroke"},{"issue":"3","key":"joi180069r10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"issue":"6","key":"joi180069r11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/acem.2010.17.issue-6","article-title":"Step-forward randomization in multicenter emergency treatment clinical trials.","volume":"17","author":"Zhao","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"6","key":"joi180069r12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cct.2011.08.004","article-title":"Block urn design\u2014a new randomization algorithm for sequential trials with two or more treatments and balanced or unbalanced allocation.","volume":"32","author":"Zhao","year":"2011","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"joi180069r13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1214\/aos\/1176344068","article-title":"The adaptive biased coin design for sequential experiments.","volume":"6","author":"Wei","year":"1978","journal-title":"Ann Stat"},{"issue":"24","key":"joi180069r14","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke.","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"issue":"9558","key":"joi180069r15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke\u2013Monitoring Study (SITS-MOST): an observational study.","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"joi180069r16","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1161\/STROKEAHA.115.009951","article-title":"Effect of intravenous recombinant tissue-type plasminogen activator in patients with mild stroke in the Third International Stroke Trial-3: post hoc analysis.","volume":"46","author":"Khatri","year":"2015","journal-title":"Stroke"},{"issue":"4","key":"joi180069r17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamaneurol.2014.4354","article-title":"Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines\u2013Stroke registry.","volume":"72","author":"Romano","year":"2015","journal-title":"JAMA Neurol"},{"issue":"8","key":"joi180069r18","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/STROKEAHA.114.005019","article-title":"Race\/ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.","volume":"45","author":"Mehta","year":"2014","journal-title":"Stroke"},{"issue":"11","key":"joi180069r19","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke.","volume":"28","author":"NINDS t-PA Stroke Study Group","year":"1997","journal-title":"Stroke"},{"issue":"2","key":"joi180069r20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/STR.0000000000000086","article-title":"Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"47","author":"Demaerschalk","year":"2016","journal-title":"Stroke"},{"issue":"6","key":"joi180069r21","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1212\/01.wnl.0000237520.88777.71","article-title":"Early MRI and outcomes of untreated patients with mild or improving ischemic stroke.","volume":"67","author":"Rajajee","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"joi180069r22","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/STROKEAHA.107.482554","article-title":"Outcome of stroke with mild or rapidly improving symptoms.","volume":"38","author":"Nedeltchev","year":"2007","journal-title":"Stroke"},{"issue":"11","key":"joi180069r23","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1161\/STROKEAHA.111.613208","article-title":"Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With the Guidelines\u2013Stroke.","volume":"42","author":"Smith","year":"2011","journal-title":"Stroke"},{"issue":"8","key":"joi180069r24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0b013e3181eee426","article-title":"Disability status at 1 month is a reliable proxy for final ischemic stroke outcome.","volume":"75","author":"Ovbiagele","year":"2010","journal-title":"Neurology"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2687354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T03:47:37Z","timestamp":1531280857000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.8496"}},"subtitle":["The PRISMS Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,7,10]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.8496","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733619565.793574851","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,10]]}}}